Novel Coronavirus Disease (COVID-19) in Italian Patients: Gender Differences in Presentation and Severity.
Saudi J Med Med Sci
; 9(1): 59-62, 2021.
Article
in English
| MEDLINE | ID: covidwho-1027955
ABSTRACT
BACKGROUND:
In the first wave of the novel coronavirus (severe acute respiratory syndrome coronavirus 2) infections, Italy experienced a heavy burden of hospital admissions for acute respiratory distress syndromes associated with the novel coronavirus disease (COVID-19). Early evidence suggested that females are less affected than males.OBJECTIVE:
This study aimed to assess the gender-related differences in presentation and severity among COVID-19 patients admitted to IRCCS San Raffaele Hospital, Milan, Italy. MATERIALS ANDMETHODS:
This prospective observational study included all patients admitted to the hospital between February 25 and April 19, 2020, with a positive real-time reverse-transcriptase polymerase chain reaction for COVID-19. The following data were collected date of admission, gender, age and details of intensive care unit admission and outcomes.RESULTS:
A total of 901 patients with COVID-19 were admitted to the hospital and provided consent for the study. Of these, 284 were female (31.5%). The percentage of admitted female patients significantly increased over time (25.9% of all admissions in the first half of the study period vs. 37.1% in the second half; P < 0.001). Females accounted for 14.4% of all COVID-19 intensive care unit admissions. There was no gender-based difference in the overall hospital mortality 20.1% for females and 19.2% for males (P = 0.8).CONCLUSIONS:
In our hospital, which was in the epicenter of the first wave of COVID-19 pandemic in Italy, female patients were few, presented late and were less critical than male patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Saudi J Med Med Sci
Year:
2021
Document Type:
Article
Affiliation country:
Sjmms.sjmms_542_20
Similar
MEDLINE
...
LILACS
LIS